Haemorrhagic cystitis following hematopoietic stem cell transplantation: Prophylaxis, diagnosis, and treatment. Guidelines from the SFGM-TC

被引:1
|
作者
Dequirez, Pierre-Luc [1 ]
Magro, Leonardo [2 ]
Alsuliman, Tamim [3 ]
Ceballos, Patrice [4 ]
Desbrosses, Yohan [5 ]
Yakoub-Agha, Ibrahim [6 ]
Guillaume, Thierry [7 ]
机构
[1] CHU Lille, Serv Urol, 2 rue Michel Polonowski, F-59000 Lille, France
[2] CHU Lille, Serv Malad Sang, 2,rue Michel Polonowski, F-59000 Lille, France
[3] Sorbonne Univ, Hop St Antoine, AP HP, Serv Hematol & Therapie Cellulaire, 184,rue Faubourg St Honore, F-75012 Paris, France
[4] CHU St Eloi, Serv Hematol Clin, 80,Ave Bertin Sans, F-34080 Montpellier 8, France
[5] CHRU Jean Minjoz, Serv Hematol, 3 Blvd Fleming, F-25030 Besancon, France
[6] Univ Lille, CHU Lille, Serv Hematol, Infinite,Inserm U1286, F-59000 Lille, France
[7] CHU Nantes, Hotel Dieu, Serv Hematol, 1 Pl Ricordeau, F-44000 Nantes, France
关键词
Allogeneic hematopoietic; stem cell transplantation; Urologic complications; Hemorrhagic cystitis; BK virus; BK-VIRUS; CYCLOPHOSPHAMIDE; ASSOCIATION; CHILDREN; THERAPY; MESNA; RISK; HSCT;
D O I
10.1016/j.bulcan.2022.01.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hemorrhagic cystitis (HC) is a common complication after allogeneic hematopoietic cell trans-plantation (allo-HCT). Its manifestations range from microscopic hematuria without urinary symptoms to extensive and prolonged macroscopic hemorrhage requiring invasive interventions that can often prolong the duration of hospitalization and result in significant morbidity. The early onset of HC is related to allo-HCT conditioning regimen, whereas the late onset form is secondary to viral infection, most commonly due to BK virus. In the framework of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) practice harmonization workshops held in Lille in September 2021, the prophylaxis, the diagnostic approach and the treatments of HC following allografting were reviewed after analysis of published studies.
引用
收藏
页码:S48 / S55
页数:8
相关论文
共 50 条
  • [1] Inborn error of metabolism and allogenic hematopoietic cell transplantation: Guidelines from the SFGM-TC
    Jubert, Charlotte
    De Berranger, Eva
    Castelle, Martin
    Dalle, Jean-Hugues
    Ouachee-Chardin, Marie
    Sevin, Caroline
    Yakoub-Agha, Ibrahim
    Brassier, Anais
    BULLETIN DU CANCER, 2023, 110 (02) : 1 - 12
  • [2] Fertility preservation and hematopoietic stem cell transplantation (SFGM-TC)
    Chevillon, Florian
    Rebotier, Marine
    Dhedin, Nathalie
    Bruno, Benedicte
    Cacciatore, Carlotta
    Charbonnier, Amandine
    Joseph, Laure
    Le Bourgeois, Amandine
    Talouarn, Marie
    Magro, Leonardo
    Lange, Virginie Barraud
    BULLETIN DU CANCER, 2025, 112 (01) : S24 - S35
  • [3] Diagnosis, prophylaxis and therapeutic management of acute GVH: Guidelines from the SFGM-TC
    Souchet, Laetitia
    Masouridi, Stavroula
    Marcais, Ambroise
    Ibrahim, Ahmad
    Chauvel, Celine
    Turquet, Eric
    Derail, Marion
    Yakoub-Agha, Ibrahim
    Crocchiolo, Roberto
    BULLETIN DU CANCER, 2023, 110 (02) : S79 - S87
  • [4] Secondary cancers following allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
    Loschi, Michael
    Alsuliman, Tamim
    Cabrera, Quentin
    Desbrosses, Yohan
    Desmier, Deborah
    Agha, Ibrahim Yakoub
    Guillaume, Thierry
    BULLETIN DU CANCER, 2024, 111 (02) : S22 - S28
  • [5] Transfusion in autologous and allogenic hematopoietic stem cell transplant: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
    Giraud, Christine
    Thibert, Jean-Baptiste
    Desbrosses, Yohan
    Debiol, Benedicte
    Alsuliman, Tamim
    Bardiaux, Laurent
    Garban, Frederic
    Thi Ngoc Phuong Huynh
    Samsonova, Olga
    Yakoub-Agha, Ibrahim
    Bruno, Benedicte
    BULLETIN DU CANCER, 2019, 106 (01) : S52 - S58
  • [6] Role of allogeneic hematopoietic cell transplantation after anti-CD19 CAR T-cell treatment: Guidelines from the SFGM-TC
    Beauvais, David
    Castilla-Llorente, Cristina
    Diral, Elisa
    Sirvent, Anne
    Vandewiele, Audrey
    Baruchel, Andre
    Yakoub-Agha, Ibrahim
    Yakouben, Karima
    BULLETIN DU CANCER, 2023, 110 (02) : S108 - S115
  • [7] Management of genetic predisposition to hematologic malignancies in patients undergoing allogeneic hematopoietic cell transplantation (HCT): Guidelines from the SFGM-TC
    Coiteux, Valerie
    Fenwarth, Laurene
    Duployez, Nicolas
    Ainaoui, Malika
    Borel, Cecile
    Polomeni, Alice
    Yakoub-Agha, Ibrahim
    Chalandon, Yves
    BULLETIN DU CANCER, 2023, 110 (02) : S13 - S29
  • [8] Preventative and therapeutic relapse strategies after allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)
    Yafour, Nabil
    Beckerich, Florence
    Bulabois, Claude Eric
    Chevallier, Patrice
    Daguindau, Etienne
    Dumesnil, Cecile
    Guillaume, Thierry
    Huynh, Anne
    Levrat, Stavroula Masouridi
    Menard, Anne-Lise
    Michallet, Mauricette
    Pautas, CCile
    Poire, Xavier
    Ravinet, Aurelie
    Yakoub-Agha, Ibrahim
    Bazarbachi, Ali
    BULLETIN DU CANCER, 2017, 104 (12) : S84 - S98
  • [9] Update for cord blood unit selection in hematopoietic stem cell transplantation (workshop SFGM-TC)
    Dubois, Valerie
    Blandin, Lucie
    Duclaut, Marion
    Duquesne, Alix
    Faivre, Lionel
    Ferru-Clement, Romain
    Roy, Jean
    Walencik, Alexandre
    Magro, Leonardo
    Garnier, Federico
    BULLETIN DU CANCER, 2025, 112 (01) : S68 - S77
  • [10] Unrelated donor selection for allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
    Cornillon, Jerome
    Crocchiolo, Roberto
    Dubois, Valerie
    Guidicelli, Gwendaline
    Jorge-Cordeiro, Debora
    Meunier, Marie-Christine
    Michiels, Sandra
    Timmermans, Aurelie
    Villemonteix, Juliette
    Yakoub-Agha, Ibrahim
    Ahmad, Imran
    BULLETIN DU CANCER, 2024, 111 (02) : S1 - S13